Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
NCT02572323
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
73
Enrollment
OTHER
Sponsor class
Conditions
Mild Cognitive Impairment
Interventions
DRUG:
Tesamorelin
Sponsor
University of California, San Diego
Collaborators
[object Object]
[object Object]
[object Object]